Iscoms in parasitological research

Parasitology Today

Volumn 12, Issue 8, 1996, Pages 320-323

  Lundén, Anna ^a   Lövgren Bengtsson, Karin ^a   Sjölander, Anders ^a   Uggla, Arvid ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ISCOM; PARASITE ANTIGEN; VACCINE;

ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOGENICITY; MEDICAL RESEARCH; NONHUMAN; PARASITOSIS; VACCINATION;

EID: 0030222054     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-4758(96)10022-3     Document Type: Article

References (40)

1. 1 Morein, B. et al. (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308, 457-160
2. 2 Özel, M. et al. (1989) Quaternary structure of the immunostimulating complex (iscom). J. Ultrastructr. Mol. Struct. Res 102, 240-248
3. 3 Lövgren, K. and Morein, B. (1988) The requirement of lipids for the formation of immunostimulating complexes (iscoms). Biotechnol. Appl. Biochem. 10, 161-172
4. 4 Lucy, J.A. and Glauert, A.M. (1964) Structure and assembly of macromolecular lipid complexes composed of globular micelles. J. Mol. Biol. 8, 727-748
5. 5 Höglund, S. et al. (1989) in Subcellular Biochemistry, Vol. 15 (R.J. Harris, ed.), pp 39-68, Plenum
6. 6 Lövgren, K. et al. (1987) A new approach to the preparation of a Toxoplasma gondii membrane antigen for use in ELISA. J. Vet. Med. B 34, 274-282
7. 7 Morein, B. et al. (1990) Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms. J. Immunol. Methods 128, 177-181
8. 8 Sjölander, S. et al. Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems. Vaccine Adjuvant Research (in press)
9. 9 Mowat, A.M. et al. (1991) Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72, 317-322
10. 10 Lövgren, K. and Larsson, M. (1994) Conjugation of synthetic peptides to carrier iscoms: factors affecting the immunogenicity of the conjugate. J. Immunol. Methods 173, 237-243
11. 11 Sjölander, A. et al. (1993) Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA. Parasite Immunol. 15, 355-359
12. 12 Sjölander, A. et al. (1991) High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. Vaccine 9, 443-450
13. 13 Lundén, A. et al. (1993) Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes. Infect. Immun. 61, 2639-2643
14. 14 Uggla, A. et al. (1988) Immunizing effects in mice of two Toxoplasma gondii iscom preparations. J. Vet. Med. B 35, 311-314
15. 15 Øvernes, G. et al. (1991) Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine. Vaccine 9, 25-28
16. 16 Lundén, A. (1995) Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. Vet. Parasitol. 56, 23-35
17. 17 Buxton, D. et al. (1989) Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep. Br. Vet. J. 145, 451-457
18. 18 Araujo, F.G. and Morein, B. (1991) Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice. Infect. Immun. 59, 2909-2914
19. 19 Kazanji, M. et al. (1994) Immune responses and protective effect in mice vaccinated with surface sporozoite protein of Eimeria falciformis in iscoms. Vaccine 12, 798-804
20. 20 Jakobsen, P.H. et al. (1991) Isolation and characterization of a soluble antigen complex of Plasmodium falciparum with pyrogenic properties. Apmis 99, 21-29
21. 21 Lockyer, M.J. et al. (1993) Immunogenicity of a hybrid Plasmodium falciparum malaria antigen. Parasitology 106, 451-457
22. 22 Sjölander, A. et al. (1993) Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs). Exp. Parasitol. 76, 134-145
23. 23 Jackson, L.A. and Opdebeeck, J.P. (1994) Quil A and ISCOMs as adjuvants for midgut membrane antigens of Boophilus microplus. Appl. Parasitol. 35, 87-98
24. 24 Hughes, H.P.A. et al. (1982) A new soluble antigen preparation of Toxoplasma gondii and its use in serological diagnosis. Clin. Exp. Immunol. 49, 239-246
25. 25 Björkman, C. et al. (1994) Neospora caninum in dogs: detection of antibodies by ELISA using an iscom antigen. Parasite Immunol. 16, 643-648
26. 26 Bergström Mollauglu, M. et al. (1992) Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms. Scand. J. Immunol. 36, 565-574
27. 27 Villacres-Eriksson, M. et al. (1993) The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells. Clin. Exp. Immunol. 93, 120-125
28. 28 Fossum, C. et al. (1990) Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix. Cell. Immunol. 129, 414-425
29. 29 Villacres-Eriksson, M. et al. (1992) Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms. Scand. J. Immunol. 36, 421-426
30. 30 Jones, P.D. et al. (1988) Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulating complexes (iscoms). Scand. J. Immunol. 27, 645-652
31. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in iscoms. Nature 344, 873-875
32. 32 Claassen, I. and Osterhaus, A. (1992) The iscom structure as an immune-enhancing moiety: experience with viral systems. Res. Immunol. 143, 531-541
33. 33 Morein, B. et al. (1995) Immunostimulating complexes; clinical potential in vaccine development. Clin. Immunother. 3, 461-475
34. 34 Morein, B. and Simons, K. (1985) Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes. Vaccine 3, 83-93
35. 35 Sjölander, A. et al. (1996) Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins. Scand. J. Immunol. 43, 164-172
36. 36 Cox, F.E.G. and Liew, F.Y. (1992) T-cell subsets and cytokines in parasitic infections. Parasitology Today 8, 371-374
37. 37 Finkelman, F.D. and Urban, J.F. (1992) Cytokines: making the right choice. Parasitology Today 8, 311-314
38. 38 Kensil, C. et al. (1991) Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146, 431-437
39. 39 Kersten, G.F. et al. (1991) On the structure of immunestimulating saponin-lipid complexes (iscoms). Biochim. Biophys. Acta 1062, 165-171
40. 40 Rönnberg, B. et al. (1995) Adjuvant activity of non-toxic Quillaja Saponaria Molina components for use in iscom-matrix. Vaccine 13, 1375-1382